Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Hysterectomy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 4 Leiomyoma 4 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Uterine Neoplasms 2 Uterine Prolapse 1 Uterine Cervical Dysplasia 1 Precancerous Conditions 1 Myofibroma 1 Metrorrhagia 1 Menstruation Disturbances 1 Menorrhagia 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Endometriosis 1 Endometrial Hyperplasia 1 Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Endometrioid 1 Carcinoma, Adenosquamous 1 Adenomyosis 1 Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Blood Specimen Collection 6 Cyclophosphamide 5 Prednisone 4 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Biopsy 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Cytarabine 2 Control Groups 2 Biopsy, Fine-Needle 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 vistusertib 1 venetoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06576362 2024-08-30

EFIBIA

Assistance Publique Hopitaux De Marseille

Phase NA Not yet recruiting

Disease, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡